Interferon-β production modulating Listeria strains and methods for using same
AssigneeThe Regents of the University of California
InventorsDaniel A. Portnoy, Anat A. Herskovits, Gregory Crimmins
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Regents of the University of California
InventorsDaniel A. Portnoy, Anat A. Herskovits, Gregory Crimmins
Estimating the term…
Mutant Listeria bacteria that modulate interferon-β production are provided. The subject bacteria are characterized by having a mutation in a gene chosen from a TetR gene, a LadR gene, a VirR gene, a MarR gene a MdrL gene, a MdrT gene and a MdrM gene. The subject bacteria find use in a variety of applications, where representative applications of interest include, but are not limited to: (a) use of the subject bacteria as adjuvants; (b) use of the subject bacteria as delivery vectors for introducing macromolecules into a cell; (c) use of the subject bacteria as vaccines for eliciting or boosting a cellular immune response; etc.
A Listeria bacterium comprising a mutation which modulates the expression of a multidrug resistance transporter gene selected from MdrT and MdrM, wherein said Listeria bacterium modulates interferon-β production in macrophages, wherein when said mutation is a mutation in a transcription regulator gene, the mutation is a mutation in the TetR or MarR gene.
A Listeria bacterium comprising a mutation which modulates the expression of a multidrug resistance transporter, wherein said Listeria bacterium modulates interferon-β production in macrophages, wherein said Listeria bacterium further comprises a mutation in a UvrA gene and/or a UvrB gene.
A method for modulating interferon-β production in a human subject, comprising:
Dependencies are inferred from the claim text.